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ABSTRACT 
Objective: In the present study, we evaluated the ethno pharmacological effect of the different doses of Turmeric rhizome hydroethanolic extract 
ointment (TRO), using in vitro antioxidant activity and in vivo excision, incision and dead space wound models in Wistar rats.  
Methods: The antioxidant activity and acute toxicity studies were performed. In excision wound model, period of epithelization time and wound 
area were monitored on days 2, 4, 6, 8, 10, 12, 14, 16, 18 and 20 using graph paper. Additionally, histological evaluation was carried out on days 3, 7, 
14 and 21. Incision wound modle and dead space, were perfomed for breaking strength value and hydroxyproline content.  
Results: The results of wound contraction and skin breaking strength a significant increased showed in wound contraction and breaking strength 
value rate, in all treatment groups with TRO, especially in high dose of TRO. Thus, results of histopathological evaluation showed that TRO 
accelerate wound healing process specifically in re-epithelization period, angiogenesis and collagen disposition in all treatment groups.  
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INTRODUCTION  
Skin is one of the largest organs in the body, which injures 
inescapably during life; these often arise due to physical or chemical 
injures and microbial infections. Following burn, organ injury and 
pathogens capable to entry into the body and sunsequently it is 
prone to infection. To minimize happening of such problems, skin 
wound healing process begins immediately [1]. Inflammation, 
proliferation and tissue remodeling are three phases of healing 
process which occurs following tissue damages [2]. Herbal 
preparations can be more effective and safety than conventional 
medicines because of their non-toxic nature which abales them to be 
administered over long periods [3]. 
Turmeric (Curcuma longa L.) is one of the main spices belongs to 
Zingiberaceae family [4], which imparts a characteristic yellow color 
to curry powder and has been used to enhance color, aroma and 
flavor of food in most regions of southern Asia [5]. Flavonoids are 
resposible for many biochemical processes in plant growth and 
development [6]. Turmeric extract contain high levels of mineral 
dyes, curcumin, curcuminoids, phenolic compounds and volatile oils 
e. g. turmerone, atlantone and zingiberene [7, 8].  
Scarce information available on effects of Turmeric rhizome hydro 
alcoholic extract on in vivo non infected wound healing. So the 
hypothesis of present study was to evaluate wound healing activities 
of Turmeric rhizome hydroalcoholic extract using in vivo 
experimental models. 
MATERIALS AND METHODS  
Plant and Hydro alcoholic extract preparation: 
Turmeric rhizome powdered (150 g) was purchased from local 
herbal market in Hamadan province, Hamadan, Iran. Specimens 
from the plant material were deposited at the Department of Botany 
Sciences, the Hamadan research Agricultural and Natural rescores 
center, Hamadan, Iran. The powder of Turmeric rhizome was 
suspended in 300 mL of an aqueous ethanol solution (7:3, v/v) for 
7PthP day at room temperature. The mixture was filtered using a fine 
muslin cloth followed by filter paper (Whatman No. 1). After 
filtration, the solvent was completely evaporated under vacuum at 
40P◦ PC in a rotary evaporator and the hydroalcoholic Turmeric 
rhizome extract was obtained after lyophilization [9]. 
Determination of ferric reducing/antioxidant power assay 
(FRAP) 
FRAP assay was carried out according to the method previously 
described by Benzie and Strain [10]. FRAP reagent was prepared 
from acetate buffer (1.6 g sodium acetate and 8 ml acetic acid make 
up to 500 ml) (pH 3.6), 10 mM TPTZ solution in 40 mM HCL and 20 
mM iron (III) chloride solution in proportion of 10:1:1 (v/v) 
respectively. The FRAP reagent was prepared fresh daily and was 
warmed to 37PoPC in the oven prior to use. A total of 50 μl sample 
extract was added to 1.5 ml of the FRAP reagent and mixed well. The 
absorbance was measured at 593 nm using using microplate reader 
spectrophotometers (Molecular devices, VERSAmax tunable, 
California, USA) after 4 min. Samples were measured in three 
replicates. Standard curve of iron (II) sulfate solution (200, 400, 600, 
800 and 1000 ppm) was prepared using the similar procedure. The 
results were expressed as μmol Fe (II) /100 g extract sample. 
Determination of total phenolics 
Total phenolic contents of all plant extracts were determined using 
Folin-Ciocalteu reagent as described by Singlaton and Rossi (1965). 
Samples were inserted into different test tube and mixed thoroughly 
with 5 ml Folin-Ciocalteu reagent (previously pre-dilute 10 times 
with distilled water). After 5 min, 4 ml of 7.6% sodium carbonate 
(Na2CO3) was added and allowed to react for 2 hrs at room 
temperature. The absorbance was measure at 765 nm using 
microplate reader spectrophotometers (Molecular devices, 
VERSAmax tunable, California, USA). Samples were measured in 
three replicates. Standard curve of gallic acid solution (10, 20, 40, 60, 
80 and 100 ppm) was prepared using the similar procedure. The 
results were expressed as mg GAE/100 g extract sample. 
Formulation of Topical Wound Application Forms 
We prepared four variants of the topical application form 
comprising of the study materials in ointment. All the variants 
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comprised of the base formulation consisting of Eucerin (30%) and 
Vaseline (70%) in about 1: 2 proportions. 
After the operation, all rats randomly were labeled by none toxic 
color and divided into four groups. Two groups served as controls: 
Group 1 (negative control) had no receive any administration and 
Group 2, placebo (positive control) animals were applied to the base 
formulation consisting of Eucerin (30%) and Vaseline (70%). Groups 
3, 4 and 5 (experimental) applied respectively, with the 1.5% (w/w), 
3% (w/w) and 6% (w/w) of powder extract mixed with base 
formulation (Turmeric rhizome extract ointment: TRO) until 
complete epithelialization. The respective ointments were topically 
applied once a day (0.5g), on the wound area to all animals in each 
respective groups, starting from the day of operation, till complete 
epithelialization. All rats were monitored until complete 
epithelialization for possibility of infection and any wound fluid or 
other abnormalities. 
Experimental animals 
Healthy inbred male Wistar albino rats weighing (165-180g) 
approximately 7 weeks of age were obtained from the experimental 
animal house, Veterinary collage of Uremia University and used in 
study. All rats were divided randomly into five groups (n=8 in each). 
The animals were kept in separate cages for four days at room 
conditions to acclimatize. Animal houses were in standard 
environmental conditions of temperature (22 ±3°C), humidity (60 ± 
5%), and a 12h light/dark cycle. The animals offered on standard 
pellet diet and fresh tap water. All rats were closely observed for any 
infection and if they showed signs of infection separated, excluded 
from the study and replaced. The study was approved by the ethics 
committee for animal experimentation by the Faculty of Veterinary 
Medicine, Islamic Azad University, Urmia Branch.  
Acute toxicity tests 
In order to find a safe dose for Turmeric rhizome hydroethanolic 
extract, acute toxicity study was conducted. twenty healthy white 
mixed sex Wistar rats (ten males and ten females), approximately 
200 g and 6 to 8 weeks of age were randomly divided into 5 groups 
of 4 animals each: Control, Placebo, 4, 8g and 12g of Turmeric 
rhizome powder groups. Animals were under surveillance for 30 
min 2, 4, 24 and 48h after administration for the onset of clinical or 
toxicological symptoms. Mortality rate was recorded in a period of 
two-week, if any. The animals were euthanized on day 14 post-test. 
Hematological, serum biochemical and histological (liver and 
kidney) parameters were determined based on the standard 
methods described by others [11].  
Circular excision Wound Model 
This model of wound was used to monitor wound closure time and 
histopathological. After induction of anesthesia with Xylazine HCL 
2% (5 mg/kg/IP/; Alfasan International, Woerden, Holland) and 
ketamine HCL 10% (60 mg/kg/IP/; Alfasan International, Woerden, 
Holland) rats were fixed in a ventral posture on a surgery table. The 
skin of the dorsal area from the scapula to the end thoracic vertebra 
was shaved with an electric clipper and scrubbed. Following on, 
create one circular, full thickness surgical wounds (20 mm diameter) 
with a surgical scalpel and scissor. Then, all animals were randomly 
divided into five groups of eight in each. This model of wound was 
used to evaluate of percentage, re-epithelialization and histology 
(histomorphometry) of wound healing. 
Subjective evaluation 
The information of wound healing such as appearance of granulation 
tissue, amount of drainage on the wound surface, complete filling of 
the wound by granulation tissue, appearance of erythema, edema or 
necrosis were also recorded by visual observation during the daily 
wound care.  
Percentage Wound Contraction 
A transparency paper and a permanent marker were used in order 
to measure and record the wound size. The wound areas in all 
groups were recorded and measured on graph paper every other 
day. Later, wound contraction was calculated as percentage of the 
reduction in wounded area. The wound healing percentage was 
calculated by Walker formula after measuring the wound size [12]. 
The percentage of wound healing was computed at the beginning of 
experiments and the next 2, 4, 6, 8, 10, 12, 14, 16, 18 and 20 days. A 
specimen sample of tissue was isolated from the healed skin of each 
group of rat for the histopathological examination. Percentage 
wound contraction was calculated as:  
Percentage of wound size =Wound area on day X / Wound area on 
day zero × 100. Percentage of wound healing = 100 - Percentage of 
wound size. 
Histologic evaluation 
In order to specimens from skin were taken in the 3, 7, 14 and 21 
days after surgery, with the rats under general anesthesia. Sample 
tissues, excised along with 1 to 2 mm surrounding normal skin and 
in a depth of approximately 3 mm, were pinned on a flat cork surface 
and fixed in neutral-buffered formalin 10%. Then sample tissues 
were routinely processed, paraffin wax embedded, sectioned at 5 
µm, and stained with Masson's trichrome stain. Stained sections 
were microscopically (by light microscope, Olympus CX31RBSF 
attached cameraman) evaluated to assess the predominant stage of 
wound healing. Three parallel sections were obtained from each 
specimen. Following factors such as cellular infiltration (the number 
of mononuclear cells, poly morphonuclear cells and Fibroblastic 
aggregation), angiogenesis (the number of blood vessels and 
capillary buds) were quantitatively evaluated in 5 per high power 
fields (HPFs)(×400) [13]. 
Incision wound model  
Animals were randomly divided into six experimental groups and six 
rats in each: Control, Placebo, 1.5%, 3% and 6% groups. All animals 
of experimental groups were anesthetized with the same way 
mentioned above and a 4-cm length incision was made through the 
skin and cutaneous muscle at a distance about 2 cm from the middle 
on right side of the depilated back. The wound was closed at 0.5 cm 
intervals using 3/0 nylon (Dafilon, B/Braun, Germany). All the 
groups were treated the same as mentioned in the excision model. 
Ointments were applied once daily for 9 days. On day 9, sutures 
were removed and the tensile strength of healed wounds was 
measured on day10 by Strongraph mechanical test frame (Toyoseiky 
Tensile Testing Unit, Model R3, Japan) [14]. 
Tensile strength was calculated using the following formula: 
Tensile strength = breaking strength (g) / cross sectional area of 
skin (mm2) 
Dead space wound model and hydroxyproline content 
estimation 
Animals were randomly divided into six experimental groups of six 
animals each: Group1 was considered as the control, group 2 was 
considered as the Placebo and groups 3, 4 and 5 were treated orally 
with 50 mg/kg, 100mg/kg and 200 mg/kg hydroethanolic extract 
suspended in 3% w/v TRO, respectively. Animals in placebo group 
received the same volume of phosphate buffered saline. The animals 
of control group had no received extract or PBS orally. Dead space 
wound was created using subcutaneous implanting of polypropylene 
tubes, 2.5 cm×0.5 cm, in the lumbar region on dorsal side [15]. All 
animals in experimental groups received extract from 0 to 9 day 
post-wounding induction. On day 10 post-wound induction, 
granuloma tissue created on implanted tube was carefully dissected 
and used to determine breaking strength and estimation of 
hydroxyproline content. 
Statistical Analysis 
Experimental results were expressed as means ± SEM. Statistical 
analyses were performed using PASW 18.0 (SPSS Inc., Chicago, IL, 
USA). Model assumptions were evaluated by examining the residual 
plot. Results were analyzed using one way ANOVA. Dunnett's test for 
pair-wise comparisons was used to examine the effect of time and 
treatments. Differences were considered significant when P < 0.05. 
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RESULTS  
Antioxidant activity and total phenolic content 
In this study, the antioxidant activity is also determined on the basis 
of the ability of antioxidant in this plant extract to reduce ferric (III) 
iron to ferrous (II) iron in FRAP reagent [16, 17]. Generally, FRAP 
assay was used due to its simplicity and reproducibility. The results 
indicated that turmeric exhibited antioxidant activity of 3.23 ± 2.55 
μmol Fe (II)/g). Total phenolic contents of Turmeric rhizome extract 
were tested using the diluted Folin-Ciocalteu reagent. The result 
clearly showed that turmeric had a mean value of total phenol 15.48 
± 0.3 mg/g dried extract.  
Acute toxicity tests 
The Results of oral administration of Turmeric rhizome powder in 
rat indicated that this plant powder at dose 12g/bw had no 
impressed any signs of toxicity. 
Wound contraction and days of re-epithelialization 
The Results of the mean wound contraction percentage and 
epithelialization period, in the excision wound repair model after 
topical administration of the Turmeric rhizome hydroethanolic 
extract ointment in different doses, is presented in table 1.  
These data revealed that rate of wound contraction percentage 
significantly higher at day 6, 8, 10, 12 and 14, was corresponding to 
treat group with ointment containing 6% TRO, compared to the 
control group (p < 0.05). On day 18 after surgery, wound contraction 
ability of 6% TRO treated group (100±0%) significantly increased 
during the wound healing process in comparision to control group 
(90.92±3.64%) (p < 0.05).  
Whenever the wound was covered with new epithelium, refers to 
epithelialization period. It is observed in table 2, the mean ± SEM 
day of epithelialization time treated group with ointment containing 
6% TRO was significantly higher on days (17.73 ± 1.68) compared to 
the control group (22.76 ± 0.49) (p < 0.05). Turmeric rhizome 
extract ointment was effective at a 6% concentration, that this result 
indicated the full-thickness skin wound healing potential of the 
Turmeric rhizome hydroethanol extract was dose dependent. 
Subjective evaluation 
Granulation of tissue was appeared in the wounds, 3 day post-
wounded in the all treatment groups with hydroethanolic extract 
and the 4 day post-wounded in the two control groups. All wounds 
were completely filled by granulation tissue within 8 days 
postoperatively, with the exception of negative control group 
wounds that were totally filled on day 12. Generally, the clinical 
appearance of the wounds (amount of drainage on the wound 
surface, complete filling of the wound by granulation tissue, the 
appearance of erythema, edema, purulent wound exudate or 
necrosis) was better than negative control and placebo groups. 
Histologic evaluation (Morphology and morphometry) 
Results of the quantitative and qualitative studies the parameters 
involved in excision wound healing, in sample tissue slides in 3PrdP, 7PthP, 14PthP 
and 21PthP days after wound creation are presented in table 2 and figure 1, 
respectively.  In histological evaluation of 1.5, 3 and 6 percent TRO 
treated groups on the 14PthP day after excision wound creation, the tissues 
demonstrated by the high newly formed blood capillaries (angiogenesis) 
(Table 3) to significant increase in neovascularization, fibroblast 
migration and higher collagen deposition (more intense blue coloration) 
in 6% treated group (Fig. 1D), compared to control group (Fig. 1A). 
 
Table 1: Effects of the TRO on percentage of circular excision wound and epithelialization period in Rat. 
 Wound area in days Period of 
epithelializati
on (days) 







































































































100Pb 100Pb 17.73±1.68Pb 
n= 6 animals in each group; TRO: hydroethanolic extracts of Turmeric rhizome extract ointment. t Values are expressed as Mean ± SEM; P* PandP ** Pis 
presented significant differences P<0.05 and P<0.01 between marked data in the same column. 
 
Table 2: Mean Distribution of immune cells (PMN and MNC), new vessels formation and fibroblasts in different groups in Rat 
 PMN MNC New vessels Fibroblast 
Control (day 3) 62.4 ± 4.1 12.1 ± 0.54 2.5 ± 2.1 21.5 ± 1.52 
TRO 1.5% (day 3) 42.7 ± 5.1P* 19.2 ± 0.95P * 5.2 ± 0.62P* 39.3 ± 1.63P* 
TRO 3% (day 3) 39.8 ± 4.2P* 23.1 ± 0.77P* 6.5 ± 1.01P* 47.8 ± 2.19P* 
TRO 6% (day 3) 22.1 ± 2.6P** 26.1 ± 0.45P** 7.8 ± 1.29P** 55.2 ± 2.38P** 
Control (day 7) 50.2 ± 3.4 14.3 ± 0.4P  3.2 ± 0.28P  35 ± 1.26 
TRO 1.5% (day 7) 33.2 ± 1.4P* 15.8 ± 0.71 4.1 ± 0.71P* 58 ± 2.12P* 
TRO 3% (day 7) 29.91 ± 0.4P* 16.5 ± 1.6P* 4.7 ± 0.29P* 67± 2.41P* 
TRO 6% (day 7) 15.12 ± 1.8P** 19.9 ± 0.8P* 5.6 ± 0.68P** 81 ± 2.25P** 
Control (day 14) 32.1 ± 1.7 9.12 ± 0.67 2.8 ± 0.81 57 ± 2.62 
TRO 1.5% (day 14) 18.4 ± 1.4P* 12.4 ± 0.58P* 1.3 ± 0.56P* 79 ± 3.91P* 
TRO 3% (day 14) 15.81 ± 0.3P* 12.8 ± 1.41P* 2.5 ± 0.88P* 85 ± 4.33P* 
TRO 6% (day 14) 8.92 ± 0.6P** 14.32 ± 1.09P* 3.6 ± 1.03P* 94 ± 4.81P** 
Control (day 21) 12.9 ± 0.9 3.3 ± 0.1 0.72 ± 0.29 28 ± 1.87 
TRO 1.5% (day 21) 5.11 ± 0.3P* 3.8 ± 0.81 0.98 ± 0.32 35 ± 2.72P* 
TRO 3% (day 21) 3.99 ± 0.5P* 3.1 ± 0.88 1.9 ± 0.68P* 42 ± 3. 42P* 
TRO 6% (day 21) 1.1 ± 0.11P** 4.3 ± 0.79P* 2.2 ± 1.09P** 49 ± 3.55P** 
TRO: hydroethanolic extracts of Turmeric rhizome extract ointment; PMN: poly morphonuclear cells; MNC: mononuclear cells. n= 6 animals in each 






Fig. 1: cross section from tissue 14 days after wound induction 
in (A) control-sham group, (B) TRO 1.5%, (C) TRO 3%, (D) TRO 
6% groups in Rat. 
 
Note well formed collagen in deep dermis and longituneal 
angiogenesis in treated animals. Hgih dose of TRO dependently 
downregulated the immune cells infiltration and enhanced collagen 
deposition in comparison to control-sham animals, Masson trichrom 
staining, 400×. Note: Fibroblasts (FB), Macrophages (M), Collagen 
(C) bundles and vascularization with new blood vessels (BV). 
Incision wound study  
For evaluation of tensile strength of new repaired tissue, we used 
linear incision wound model. As shown in table 3, application of the 
Turmeric rhizome hydroethanolic extracts ointments onto the 
incised wounds, cause the significantly higher rate of mean ± SEM 
tensile strength in treatment groups 6% (498.08 ± 9.68) and 3% 
(449.81 ± 6.99) TRO compared control group (268.01± 4.60) on day 
10 (p < 0.05). 
 
Table 3: Effect of TRO on linear incision wound model in Rat. 
Groups Statistical mean ± SEM 
Control 268.01± 4.60 
Placebo 282.48± 4.75 
TRO 1.5% 357.88 ± 4.88P* 
TRO 3% 449.81 ± 6.99P * 
TRO 6% 498.08 ± 9.68P ** 
n= 6 animals in each group; Values are expressed as Mean ± SEM; P* 
PandP ** Pis presented significant differences P<0.05 and P<0.01. 
TRO: hydroethanolic extracts of Turmeric rhizome extract ointment 
 
Table 4: Effect of TRO on wound healing of the dead space 
wound model in Rat. 
 
Groups 




Wet weight of 
the granulation 
tissue (mg) 
Dry weight of 
the granulation 
tissue (mg) 
Control 12.11 ± 0.42 77.48 ± 4.9 12.31 ± 0.83 
Placebo 12.66 ± 0.24 78.01 ± 5.44 12.45 ± 0.71 
TRO 
1.5% 
13.61 ± 0.18 90.85 ± 2.86P* 14.25 ± 0.51 
TRO 
3% 
14.83 ± 0.19P* 109.16 ± 3.88P* 15.66 ± 0.52P* 
TRO 
6% 
15.51 ± 0.38P** 118.94 ± 2.48P** 19.97 ± 0.85P** 
 
Dead space 
For assessment of Hydroxyproline content, wet weight of the 
granulation tissue (mg), Dry weight of the granulation tissue Dead 
space wound model was performed. According to our analyses of the 
dead space wound model, the hydroxylproline content, dry and wet 
weights of granulation tissue of the TRO -treated animals increased 
depending on administrated dose. Intrestingly, in animals treated with 
topical ointments 3% and 6% TRO represented the greatest 
hydroxyproline content versus to those at 1.5% TRO and non-treated 
groups. Similar to the results for hydroxyproline, the animals treated 
with TRO showed significantly higher dry and wet weights of 
granulation tissue in comparison to non-treated animals (P<0.05) 
(table 4). 
DISCUSSION AND CONCLUSIONS 
The phytochemical analysis of rhizome parts of Turmeric revealed 
presence of phenols in extract. Phenols and flavonoids have 
therapeutic uses due to their anti-inflammatory, antimicrobial, anti-
fungal, antioxidant, wound healing and astringent properties which 
accelerating the process of wound contraction and epithelialization 
[13, 18]. Recently, curcumin demonstrated that chemo preventive 
and anticancer effects in several human cancers [19, 20]. The 
present study established the anti-oxidant activity Turmeric 
rhizome hydroethanolic extract. A number of studies reveal that 
curcumin (diferuloylmethane), is the active component of turmeric, an 
important role in treatment and/or has supporting role in various 
inflammatory conditions including arthritis, bronchitis, fever, diarrhea 
and relieve pain [21, 22, 23], anti-cancer effects [19, 20, 23], would 
healing effect [24, 25, 26].  
Inflammation, proliferation and tissue remodeling are three phases 
of wound healing process which occurs following tissue damages as 
closely as possible to its natural state. The healing process is 
activated when platelets come into contact with exposed collagen 
leading to platelet aggregation and the release of clotting factors 
resulting in the deposition of a fibrin clot at the site of injury. The 
fibrin clot serves as a provisional matrix and sets the stage for the 
subsequent events of healing. Inflammatory cells also arrive along 
with the platelets at the injury site providing key signals known as 
growth factors. Fibroblast is the connective tissue cell responsible 
for collagen deposition required to repair the tissue injury. Collagen 
is the main constituent of extra cellular tissue, which is responsible 
for support and strength [2]. 
Hence, in the present study, to evaluate the effect of Turmeric 
rhizome hydroethanolic extract in deferential doses were used 
excision and incision wound models.  
Histopathological study on day 3 or 4 after excision wound model 
creation, showed the coincidence significantly decrease of 
neutrophils count and increased the macrophages count onto the 
wound site; which these results were consistent other researcher 
findings (table 2). 
Also the histopathological study on day 7 after excision wound 
model creation, showed a significant increase in tissue granulation 
formation, fibroblasts cells  migration in all treatment groups, 
especially in treated group with 6% TRO compared to control group 
which may be due to increase in new blood vessel formation, 
increased levels of interleukin-8 secretion, due to the higher number 
of macrophage cells in wound site (table 2), and anti-oxidant activity 
of Turmeric hydroethanolic extract in treatment groups. This result 
were consistent other researcher findings [27, 28].  
Histopathological study in two and three weeks post wound model 
creation, showed the collagen synthesis, collagen deposition and the 
quality and quantity of collagen bundles in the wound site (table 2). 
Increase in collagen concentration and stabilization of the collagen 
fibers, as a major component of extracellular tissue, may be cause 
the increase in tensile strength value in incision wound model [29], 
and also increase in rate of wound contraction in excision wound 
model. In our study, tensile strength and wound contraction, 
especially in treatment group with 6% TRO, was significantly 
increased compared to control group. Our results were consistent 
(wound size reduction), the findings Merrella JG, which was done on 
diabetic mice [26].  
On the other hand, one of biochemical marker for tissue collagen is 
hydroxylproline [23, 18]. The amount of collagen synthesis onto 
wound, reflected to amount of hydroxylproline content in 
granulation tissues, which hydroxylproline is involved in the wound-
healing; As shown in Table 4, in our study, topical application of 
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Turmeric hydroethanolic extract ointment leads to increase of 
hydroxylproline content of granulation tissues in all treatment 
groups, especially in treatment group with 6% TRO, compared to 
control group.  
In conclusion, according to our results, topical administration of 
differential doses of hydroethanolic extract of Turmeric rhizome, 
especially topical ointment 6% compared to other doses and two 
control groups, remarkable promote wound healing activity with 
increase in the rate of wound contraction and re-epithelialization, 
tensile strength value and collagen deposition in rat as an in vivo 
experimental wound models, and it may be suggested for treating 
various types of wounds in animal and human beings. 
Also our result show that use of Turmeric rhizome hydroethanolic 
extracts in various doses had no adverse effect no mortality during 
the experiment, which implay that extract of this plant had no toxic 
activity and change on the skin such as type of irritation and even 
noticeable inflammation or swelling. 
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